Article and Video CATEGORIES
Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)
This slide presentation is the second part of a lecture I gave at the Seattle-based non-profit Cancer Lifeline a few months ago. This covers the evidence supporting post-operative (adjuvant) chemotherapy for patients with early stage NSCLC, the need to recognize that this does not apply to all patients who have undergone surgery, and the emerging clinical research and ongoing trials that may lead to improvements in our cure rate for early stage NSCLC patients in the future.
Here is the presentation in video format, the audio version, transcript, and a pdf file of the figures. I hope it's helpful.
[powerpress]
Cancer Lifeline Part 2 Adjuvant Therapy Early Stage NSCLC Audio Podcast
cancer-lifeline-part-2-adjuvant-therapy-early-stage-nsclc-transcript
cancer-lifeline-part-2-adjuvant-therapy-early-stage-nsclc-figures
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Recent Comments
That's…